Improved outcomes with quality improvement interventions in pediatric inflammatory bowel disease

Charles M. Samson, Pamela Morgan, Elizabeth Williams, Lee Beck, RicJunette Addie-Carson, Stacy Mcintire, Andrea Booth, Eduardo Mendez, Carolyn Luzader, Gitit Tomer, Shehzad Saeed, Edward Donovan, John Bucuvalas, Lee A. Denson

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Objectives: Variations in chronic illness care are common in our health care system and may lead to suboptimal outcomes. Specifically, inconsistent use and suboptimal medication dosing have been demonstrated in the care of patients with inflammatory bowel disease (IBD). Quality improvement (QI) efforts have improved outcomes in conditions such as asthma and diabetes mellitus, but have not been well studied in IBD. We hypothesized that QI efforts would lead to improved outcomes in our pediatric IBD population. Methods: A QI team was formed within our IBD center in 2005. By 2007, we began prospectively capturing physician global assessment (PGA) and patient-reported global assessment. Significant QI interventions included creating evidence-based medication guidelines, joining a national QI collaborative, initiation of preclinic planning, and monitoring serum 25-hydroxyvitamin D. Results: From 2007 to 2010, 505 patients have been followed at our IBD center. During this time, the frequency of patients in clinical remission increased from 59% to 76% (P<0.05), the frequency of patients who report that their global assessment is >7 increased from 69% to 80% (P<0.05), and the frequency of patients with a Short Pediatric Crohn's Disease Activity Index (sPCDAI) <15 increased from 60% to 77% (P<0.05). The frequency of repeat steroid use decreased from 17% to 10% (P<0.05). We observed an association between the use of a vitamin D supplement (P=0.02), serum 25-hydroxyvitamin D (P<0.05), and quiescent disease activity. Conclusions: Our results show that significant improvements in patient outcomes are associated with QI efforts that do not rely on new medication or therapies.

Original languageEnglish (US)
Pages (from-to)679-688
Number of pages10
JournalJournal of Pediatric Gastroenterology and Nutrition
Volume55
Issue number6
DOIs
StatePublished - Dec 2012
Externally publishedYes

Fingerprint

Quality Improvement
Inflammatory Bowel Diseases
Pediatrics
Serum
Vitamin D
Patient Care
Diabetes Mellitus
Chronic Disease
Asthma
Steroids
Guidelines
Delivery of Health Care
Physicians
Population

Keywords

  • Care guidelines
  • Chronic illness
  • Fecal calprotectin
  • Serum 25-OHD
  • Vitamin D

ASJC Scopus subject areas

  • Gastroenterology
  • Pediatrics, Perinatology, and Child Health

Cite this

Samson, C. M., Morgan, P., Williams, E., Beck, L., Addie-Carson, R., Mcintire, S., ... Denson, L. A. (2012). Improved outcomes with quality improvement interventions in pediatric inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition, 55(6), 679-688. https://doi.org/10.1097/MPG.0b013e318262de16

Improved outcomes with quality improvement interventions in pediatric inflammatory bowel disease. / Samson, Charles M.; Morgan, Pamela; Williams, Elizabeth; Beck, Lee; Addie-Carson, RicJunette; Mcintire, Stacy; Booth, Andrea; Mendez, Eduardo; Luzader, Carolyn; Tomer, Gitit; Saeed, Shehzad; Donovan, Edward; Bucuvalas, John; Denson, Lee A.

In: Journal of Pediatric Gastroenterology and Nutrition, Vol. 55, No. 6, 12.2012, p. 679-688.

Research output: Contribution to journalArticle

Samson, CM, Morgan, P, Williams, E, Beck, L, Addie-Carson, R, Mcintire, S, Booth, A, Mendez, E, Luzader, C, Tomer, G, Saeed, S, Donovan, E, Bucuvalas, J & Denson, LA 2012, 'Improved outcomes with quality improvement interventions in pediatric inflammatory bowel disease', Journal of Pediatric Gastroenterology and Nutrition, vol. 55, no. 6, pp. 679-688. https://doi.org/10.1097/MPG.0b013e318262de16
Samson, Charles M. ; Morgan, Pamela ; Williams, Elizabeth ; Beck, Lee ; Addie-Carson, RicJunette ; Mcintire, Stacy ; Booth, Andrea ; Mendez, Eduardo ; Luzader, Carolyn ; Tomer, Gitit ; Saeed, Shehzad ; Donovan, Edward ; Bucuvalas, John ; Denson, Lee A. / Improved outcomes with quality improvement interventions in pediatric inflammatory bowel disease. In: Journal of Pediatric Gastroenterology and Nutrition. 2012 ; Vol. 55, No. 6. pp. 679-688.
@article{34a4e72089e242ca836a736fe68d6e18,
title = "Improved outcomes with quality improvement interventions in pediatric inflammatory bowel disease",
abstract = "Objectives: Variations in chronic illness care are common in our health care system and may lead to suboptimal outcomes. Specifically, inconsistent use and suboptimal medication dosing have been demonstrated in the care of patients with inflammatory bowel disease (IBD). Quality improvement (QI) efforts have improved outcomes in conditions such as asthma and diabetes mellitus, but have not been well studied in IBD. We hypothesized that QI efforts would lead to improved outcomes in our pediatric IBD population. Methods: A QI team was formed within our IBD center in 2005. By 2007, we began prospectively capturing physician global assessment (PGA) and patient-reported global assessment. Significant QI interventions included creating evidence-based medication guidelines, joining a national QI collaborative, initiation of preclinic planning, and monitoring serum 25-hydroxyvitamin D. Results: From 2007 to 2010, 505 patients have been followed at our IBD center. During this time, the frequency of patients in clinical remission increased from 59{\%} to 76{\%} (P<0.05), the frequency of patients who report that their global assessment is >7 increased from 69{\%} to 80{\%} (P<0.05), and the frequency of patients with a Short Pediatric Crohn's Disease Activity Index (sPCDAI) <15 increased from 60{\%} to 77{\%} (P<0.05). The frequency of repeat steroid use decreased from 17{\%} to 10{\%} (P<0.05). We observed an association between the use of a vitamin D supplement (P=0.02), serum 25-hydroxyvitamin D (P<0.05), and quiescent disease activity. Conclusions: Our results show that significant improvements in patient outcomes are associated with QI efforts that do not rely on new medication or therapies.",
keywords = "Care guidelines, Chronic illness, Fecal calprotectin, Serum 25-OHD, Vitamin D",
author = "Samson, {Charles M.} and Pamela Morgan and Elizabeth Williams and Lee Beck and RicJunette Addie-Carson and Stacy Mcintire and Andrea Booth and Eduardo Mendez and Carolyn Luzader and Gitit Tomer and Shehzad Saeed and Edward Donovan and John Bucuvalas and Denson, {Lee A.}",
year = "2012",
month = "12",
doi = "10.1097/MPG.0b013e318262de16",
language = "English (US)",
volume = "55",
pages = "679--688",
journal = "Journal of Pediatric Gastroenterology and Nutrition",
issn = "0277-2116",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Improved outcomes with quality improvement interventions in pediatric inflammatory bowel disease

AU - Samson, Charles M.

AU - Morgan, Pamela

AU - Williams, Elizabeth

AU - Beck, Lee

AU - Addie-Carson, RicJunette

AU - Mcintire, Stacy

AU - Booth, Andrea

AU - Mendez, Eduardo

AU - Luzader, Carolyn

AU - Tomer, Gitit

AU - Saeed, Shehzad

AU - Donovan, Edward

AU - Bucuvalas, John

AU - Denson, Lee A.

PY - 2012/12

Y1 - 2012/12

N2 - Objectives: Variations in chronic illness care are common in our health care system and may lead to suboptimal outcomes. Specifically, inconsistent use and suboptimal medication dosing have been demonstrated in the care of patients with inflammatory bowel disease (IBD). Quality improvement (QI) efforts have improved outcomes in conditions such as asthma and diabetes mellitus, but have not been well studied in IBD. We hypothesized that QI efforts would lead to improved outcomes in our pediatric IBD population. Methods: A QI team was formed within our IBD center in 2005. By 2007, we began prospectively capturing physician global assessment (PGA) and patient-reported global assessment. Significant QI interventions included creating evidence-based medication guidelines, joining a national QI collaborative, initiation of preclinic planning, and monitoring serum 25-hydroxyvitamin D. Results: From 2007 to 2010, 505 patients have been followed at our IBD center. During this time, the frequency of patients in clinical remission increased from 59% to 76% (P<0.05), the frequency of patients who report that their global assessment is >7 increased from 69% to 80% (P<0.05), and the frequency of patients with a Short Pediatric Crohn's Disease Activity Index (sPCDAI) <15 increased from 60% to 77% (P<0.05). The frequency of repeat steroid use decreased from 17% to 10% (P<0.05). We observed an association between the use of a vitamin D supplement (P=0.02), serum 25-hydroxyvitamin D (P<0.05), and quiescent disease activity. Conclusions: Our results show that significant improvements in patient outcomes are associated with QI efforts that do not rely on new medication or therapies.

AB - Objectives: Variations in chronic illness care are common in our health care system and may lead to suboptimal outcomes. Specifically, inconsistent use and suboptimal medication dosing have been demonstrated in the care of patients with inflammatory bowel disease (IBD). Quality improvement (QI) efforts have improved outcomes in conditions such as asthma and diabetes mellitus, but have not been well studied in IBD. We hypothesized that QI efforts would lead to improved outcomes in our pediatric IBD population. Methods: A QI team was formed within our IBD center in 2005. By 2007, we began prospectively capturing physician global assessment (PGA) and patient-reported global assessment. Significant QI interventions included creating evidence-based medication guidelines, joining a national QI collaborative, initiation of preclinic planning, and monitoring serum 25-hydroxyvitamin D. Results: From 2007 to 2010, 505 patients have been followed at our IBD center. During this time, the frequency of patients in clinical remission increased from 59% to 76% (P<0.05), the frequency of patients who report that their global assessment is >7 increased from 69% to 80% (P<0.05), and the frequency of patients with a Short Pediatric Crohn's Disease Activity Index (sPCDAI) <15 increased from 60% to 77% (P<0.05). The frequency of repeat steroid use decreased from 17% to 10% (P<0.05). We observed an association between the use of a vitamin D supplement (P=0.02), serum 25-hydroxyvitamin D (P<0.05), and quiescent disease activity. Conclusions: Our results show that significant improvements in patient outcomes are associated with QI efforts that do not rely on new medication or therapies.

KW - Care guidelines

KW - Chronic illness

KW - Fecal calprotectin

KW - Serum 25-OHD

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=84870945662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870945662&partnerID=8YFLogxK

U2 - 10.1097/MPG.0b013e318262de16

DO - 10.1097/MPG.0b013e318262de16

M3 - Article

VL - 55

SP - 679

EP - 688

JO - Journal of Pediatric Gastroenterology and Nutrition

JF - Journal of Pediatric Gastroenterology and Nutrition

SN - 0277-2116

IS - 6

ER -